4//SEC Filing
DOUGLAS RICHARD 4
Accession 0000950170-25-085441
CIK 0001341235other
Filed
Jun 11, 8:00 PM ET
Accepted
Jun 12, 4:27 PM ET
Size
10.2 KB
Accession
0000950170-25-085441
Insider Transaction Report
Form 4
DOUGLAS RICHARD
Director
Transactions
- Award
Stock Option (Right to Buy)
2025-06-10+14,476→ 14,476 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (14,476 underlying) - Award
Stock Option (Right to Buy)
2025-06-10+1,689→ 1,689 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (1,689 underlying) - Award
Stock Option (Right to Buy)
2025-06-10+62,728→ 62,728 totalExercise: $2.69Exp: 2035-06-09→ Common Stock (62,728 underlying)
Footnotes (3)
- [F1]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Board of Directors of the Issuer through the applicable vesting date.
- [F2]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as the Chairperson of the Board of Directors of the Issuer through the applicable vesting date.
- [F3]Exercisable with respect to 100% of the shares on the one-year anniversary of the grant date, provided that the Reporting Person provides continuous service as a member of the Nominating/Corporate Governance Committee of the Board of Directors of the Issuer through the applicable vesting date.
Documents
Issuer
Aldeyra Therapeutics, Inc.
CIK 0001341235
Entity typeother
IncorporatedMA
Related Parties
1- filerCIK 0001021015
Filing Metadata
- Form type
- 4
- Filed
- Jun 11, 8:00 PM ET
- Accepted
- Jun 12, 4:27 PM ET
- Size
- 10.2 KB